Document is current
Any future updates will be listed below
-
Authors
Laliberte, Jason P.
Cai, Yingyun
Kenny, Tara
Zhang, Yi
Ren, Kuishu
Rosenthal, Kim
Flores, Daniel
Roque, Richard
Acton, Oliver
Peano, Vanessa Cadevilla
Janney, Noel
Puri, Vinita
Siddiqui, Sarah
Pack, Angela
Padilla, Giune
Diallo, Seme
Adissu, Hibret
Choudhary, Rakesh
Pruitt, Hawley
Cheng, Yi-Han
Thom, George
Newton, Michael
Kurokawa, Cheyne
Guest, Johnathan
Swanson, Phillip
Loo, Yueh-Ming
Francica, Joseph R.
Blair, Wade
Esser, Mark
- License Information
-
More Information
Article History
Received: 21 July 2025
Accepted: 29 October 2025
First Online: 13 December 2025
Competing interests
: J.P.L., Y.C., T.K., Y.Z., K.R., K.R., D.F., R.R., O.A., V.C.P., N.J., V.P., S.S., A.P., G.P., S.D., H.A., H.P., Y.-H.C., G.T., M.N., J.G., P.S., J.R.F., M.E. are current employees of AstraZeneca and hold or may hold stock in AstraZeneca. R.C., C.K., Y.-M.L., and W.B. are previous employees of AstraZeneca and hold or may hold stock in AstraZeneca. AstraZeneca has filed patent applications (WO/2024/153794 and US20240277834) related to mRNA-VLP and mRNA vaccines. All other authors declare no competing interests.
